---
kind: "section"
citation: "12 C.F.R. § 265.13"
title: "12"
number: "265.13"
heading: "Functions delegated to the Director of the Division of Financial Stability."
url: "https://uscodex.org/cfr/12/265.13"
---

# §265.13. Functions delegated to the Director of the Division of Financial Stability.


The Director of the Division of Financial Stability (or the Director's delegatee) is authorized:

- (a) **Bank holding companies; savings and loan holding companies; financial holding companies; change in bank control; mergers—**
  - (1) **Stress tests.**
    - (i) Jointly with the Director of the Division of Supervision and Regulation, with the concurrence of the Chair of the Committee on Supervision and Regulation:
      - (A) To develop and issue scenarios, including, but not limited to, the baseline scenario and the severely adverse scenario, that the Board would use to conduct analyses under [§ 238.132](/cfr/12/238.132.md) of Regulation LL ([12 CFR 238.132](/cfr/12/238.132.md)) or [§ 252.44](/cfr/12/252.44.md) of Regulation YY ([12 CFR 252.44](/cfr/12/252.44.md)) and that a company would use to conduct its stress tests under [§ 238.143](/cfr/12/238.143.md) of Regulation LL ([12 CFR 238.143](/cfr/12/238.143.md)) or [§ 252.14](/cfr/12/252.14.md) or [§ 252.54](/cfr/12/252.54.md) of Regulation YY (12 CFR [252.14](/cfr/12/252.14.md) or [252.54](/cfr/12/252.54.md)), as appropriate, provided that no significant policy issues are raised; and
      - (B) To develop and issue additional scenarios or additional components for use in the severely adverse scenario under § [238.132(b)](/cfr/12/238.132.md?p=b) and [238.143(b)(2)](/cfr/12/238.143.md?p=b-2) and [(3)](/cfr/12/238.143.md?p=b-3) of Regulation LL (12 CFR [238.132(b)](/cfr/12/238.132.md?p=b) and [238.143(b)(2)](/cfr/12/238.143.md?p=b-2) and [(3)](/cfr/12/238.143.md?p=b-3)), and §§ [252.14(b)(2)](/cfr/12/252.14.md?p=b-2) and [(3)](/cfr/12/252.14.md?p=b-3), [252.44(b)](/cfr/12/252.44.md?p=b), and [252.54(b)(2)](/cfr/12/252.54.md?p=b-2) and [(3)](/cfr/12/252.54.md?p=b-3) of Regulation YY (12 CFR [252.14(b)(2)](/cfr/12/252.14.md?p=b-2) and [(3)](/cfr/12/252.14.md?p=b-3), [252.44(b)](/cfr/12/252.44.md?p=b), and [252.54(b)(2)](/cfr/12/252.54.md?p=b-2) and [(3)](/cfr/12/252.54.md?p=b-3)), that the Board would use to conduct analyses under [§ 238.132](/cfr/12/238.132.md) of Regulation LL ([12 CFR 238.132](/cfr/12/238.132.md)) or [§ 252.44](/cfr/12/252.44.md) of Regulation YY ([12 CFR 225.44](/cfr/12/225.44.md)) and that a company would use to conduct its stress tests under [§ 238.143](/cfr/12/238.143.md) of Regulation LL ([12 CFR 238.143](/cfr/12/238.143.md)) or [§ 252.14](/cfr/12/252.14.md) or [§ 252.54](/cfr/12/252.54.md) of Regulation YY (12 CFR [252.14](/cfr/12/252.14.md) or [252.54](/cfr/12/252.54.md)), as appropriate, provided that no significant policy issues are raised;
  - (2) [Reserved]
- (b) **Capital plans.**
  - (1) Jointly with the Director of the Division of Supervision and Regulation, with the concurrence of the Vice Chair for Supervision:
    - (i) To provide a firm subject to the Board's capital plan rules with notice of its stress capital buffer requirement and an explanation of the results of the supervisory stress test pursuant to [§§ 225.8(h)(1)](/cfr/12/225.8.md?p=h-1) of Regulation Y ([12 CFR 225.8(h)(1)](/cfr/12/225.8.md?p=h-1)) and 238.170(h)(1) of Regulation LL ([12 CFR 238.170(h)(1)](/cfr/12/238.170.md?p=h-1)); and
    - (ii) To provide a firm subject to the Board's capital plan rules with its final stress capital buffer requirement and confirmation of its final planned capital distributions pursuant to [§§ 225.8(h)(4)(i)](/cfr/12/225.8.md?p=h-4-i) of Regulation Y ([12 CFR 225.8(h)(4)(i)](/cfr/12/225.8.md?p=h-4-i)) and 238.170(h)(4)(i) of Regulation LL ([12 CFR 238.170(h)(4)(i)](/cfr/12/238.170.md?p=h-4-i)).
  - (2) [Reserved]

## Notes

### Amendments

[87 FR 54003, Sept. 1, 2022, as amended at 88 FR 32622, May 22, 2023]

### Authority

Authority: 12 U.S.C. 248(i) and (k).

### Source

Source: 87 FR 54003, Sept. 1, 2022, unless otherwise noted.

### Amendments

[87 FR 54003, Sept. 1, 2022, as amended at 88 FR 32622, May 22, 2023]